Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Panel Rejects Medtronic Heart Monitor Device - Medical Product Outsourcing

FDA Panel Rejects Medtronic Heart Monitor Device

Federal health advisers recommended Thursday that the government not approve Medtronic’s implantable device designed to detect worsening heart failure, according to the Associated Press.

The recommendation to the FDA against the Minneapolis, MN-based company’s Chronicle Implantable Hemodynamic Monitor came on a 9-2 vote. The FDA isn’t required to follow its advisory committees’ advice, but it does so most of the time.

A study of the device, made by the medical device manufacturer suggested it isn’t effective.

The Minneapolis-based company’s device works by taking heart rate, temperature, pressure and patient activity measurements. The data can be downloaded by doctors in the office or securely transmitted to the Web for viewing.

Medtronic is studying a defibrillator that incorporates the monitoring technology.

“We continue to believe in the benefit of this sound technology and intend to work in close collaboration with the FDA to define the appropriate path for approval,” said Dr. David M. Steinhaus. He is Medtronic’s vice president and medical director of cardiac rhythm disease management.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters